D-0619-2020 Class III Terminated

Recalled by Glenmark Pharmaceuticals Inc., USA — Mahwah, NJ

FDA drug recall D-0619-2020 was initiated by Glenmark Pharmaceuticals Inc., USA on Nov 15, 2019 and is designated Class III. Reason for recall: Defective delivery system; product is not foaming or is coming out as liquid. The recall status is terminated (terminated Mar 15, 2024). Affected quantity: a) 480 packs; b) 240 packs.

Recall details

Product Type
Drugs
Report Date
Dec 18, 2019
Initiation Date
Nov 15, 2019
Termination Date
Mar 15, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
a) 480 packs; b) 240 packs

Product description

Clobetasol Propionate Foam (Emulsion Formulation), 0.05% a) 50 g pack (NDC 68462-625-27) and b) 100 g pack (NDC 68462-625-94), Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited Plot No. B-25, MIDC, Shendra Aurangabad, Maharashtra -431210, India Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430

Reason for recall

Defective delivery system; product is not foaming or is coming out as liquid.

Distribution pattern

Nationwide

Code information

Lot 14190067, exp Jul-2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0619-2020
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0619-2020. Report a data issue: hello@regdatalab.com.